Below is a chart showing VSM's trailing twelve month trading history, with the $30 strike highlighted in orange: Today's Most Active Call & Put Options of the S&P 500 » Mylan NV (MYL) saw options trading volume of …
trading volume
Mylan stock dropped 18% Thursday, the day after the generic pharmaceutical company announced its $7.2 billion acquisition of Swedish drugmaker Meda. Netherlands-based Mylan (myl) had also reported fourth …
Fortune
In an 8-K filing, generic drug maker Mylan N.V. (MYL - Free Report) revealed restructuring programs in certain locations in an attempt to streamline its operations globally as it focuses on the integration of acquired …
ZACKS3mon
Mylan's second-quarter earnings miss hasn't helped the stock catch up with competitors -- even as excitement swirls around the drugmaker's major acquisition of a portion of Abbott Laboratories' generic business, a move …
The Motley Fool
The lower the PEG ratio, the more the stock is undervalued in relation to its earnings performance. Volume Mylan N.V. has a 52-week low of 28.66% and 52-week high of -14.23%. The company has a 20-day simple moving …
earnings
The company, which trades on the Tel Aviv Stock Exchange, managed some $50 billion in assets ... although none were recalled in the U.S. …
Jared Kushner
Mylan could be facing another issue when it comes to the EpiPen, a drug used to treat severe allergic reactions that has seen a price increase of more than 500% since 2007. The company's stock was down by more than …
Overcharging
That’s the case with Teva Pharmaceutical’s $82 a share cash and stock bid for generic competitor Mylan, a direct challenge to Mylan’s near $30 billion takeover bid for Perrigo, unveiled on April 8. The question now is whether …
Stock
Mylan N.V. (NASDAQ: MYL) has been all over the news recently... And the news isn’t good. In case you’re unaware, the company has raised the price of its lifesaving EpiPen - the only drug of its kind with FDA …
Stock